FDA Approved: ETHAMBUTOL HYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ethambutol Hydrochloride submitted by Marlex Pharmaceuticals under NDA 016320.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Ethambutol hydrochloride (Ethambutol hydrochloride)

Snippet

SUPPL AP for ETHAMBUTOL HYDROCHLORIDE (ETHAMBUTOL HYDROCHLORIDE)